共 50 条
Sequential Pneumatic Compression in the Arm in Neurocritical Patients with a Peripherally Inserted Central Venous Catheter: A Randomized Trial
被引:6
|作者:
Rabinstein, Alejandro A.
[1
]
Hellickson, Jodi D.
[2
]
Macedo, Thanila A.
[3
]
Lewis, Bradley D.
[3
]
Mandrekar, Jay
[4
]
McBane, Robert D.
[5
]
机构:
[1] Mayo Clin, Dept Neurol, 200 First St SW, Rochester, MN 55905 USA
[2] Mayo Clin, Dept Nursing, Rochester, MN 55905 USA
[3] Mayo Clin, Dept Radiol, Rochester, MN 55905 USA
[4] Mayo Clin, Dept Hlth Sci Res, Div Biomed Stat & Informat, Rochester, MN 55905 USA
[5] Mayo Clin, Dept Cardiovasc Med, Rochester, MN 55905 USA
关键词:
Deep venous thrombosis;
Upper extremity;
Intermittent pneumatic compression;
Sequential compression device;
DEEP-VEIN THROMBOSIS;
RISK;
PREVENTION;
REDUCTION;
D O I:
10.1007/s12028-019-00765-w
中图分类号:
R4 [临床医学];
学科分类号:
1002 ;
100602 ;
摘要:
Background Peripherally inserted central venous catheters (PICCs) are increasingly used for parenteral access in critically ill hospitalized patients, but they increase the incidence of upper extremity deep venous thrombosis (UE DVT). Sequential compression devices (SCDs) applied to the legs effectively reduce lower extremity DVT, but have not been tested in the arms. Our objective was to determine whether SCDs applied to the arm may reduce the risk of PICC-associated UE DVT. Methods This was a retrospective study of randomized, single-center, controlled clinical trial on patients hospitalized in the intensive care unit with critical neurological illness who had a PICC and were not receiving anticoagulants. Between January 2014 and October 2016, patients were randomized 1:1 to an intervention group having a custom SCD applied to the arm harboring the PICC or to a control group. The primary endpoint was ultrasound-detected UE DVT. Results Following randomization of 77 subjects, the study was terminated due to excess DVT in the treatment arm. UE DVT was detected in 18 subjects (29.0%), and it was more frequent among those in the SCD group (13/31 [41.9%] vs. the control group 5/31 [16.1%]; p = 0.049). After accounting for crossovers, the difference was still significant (12/28 [43.0%] vs. 6/34 [17.6%]; p = 0.048). Yet, symptomatic UE DVT (n = 3) and pulmonary embolism without evidence of lower extremity DVT (n = 2) were only observed in patients who were not wearing the SCD on the arm. Conclusions Although UE DVT is commonly associated with PICC use, the results of this trial do not support the use of SCD on the arm for DVT prevention. Further research on this strategy may nonetheless be justified.
引用
收藏
页码:187 / 192
页数:6
相关论文